Cilostazol [cilostazol]
topical
14
- Terms
-
Cilozek
Claudienne
Noclaud
Pladizol
-
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
OPC 13013
OPC-13013
Pletal
Persistent link
https://www.medvik.cz/link/D000077407
Definition
A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke.
- DUI
- D000077407 MeSH Browser
- CUI
- M0132637
- CAS
- 2(1H)-Quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-
- History note
- 2019 (1985)
- Public note
- 2019; CILOSTAZOL was indexed under TETRAZOLES 1985-2018
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.383.129.617.264
Cefozopran
D03.633.100.810.200
Ethoxyquin
D03.633.100.810.553
Pyrroloiminoquinones
D03.633.100.810.850
Quipazine
4'-trans-hydroxy cilostazol Chemical MeSH Browser